Wang, J.-N. et al. 2020. Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy. Acta Oncologica. 59, 3 (Mar. 2020), 302–305. DOI:https://doi.org/10.1080/0284186X.2019.1670355.